Does transcatheter mitral valve replacement (TMVR) provide durable resolution of MR and functional improvement in patients with symptomatic MR?
In a real-world registry, TMVR provided durable MR resolution and functional improvement at 2 years, though mortality remained high at 38.1%, highlighting the need for optimized patient selection and access site management.
In this real-world registry of patients with symptomatic MR undergoing TMVR, treatment with TMVR was associated with a durable resolution of MR and significant functional improvement at 2 years. Two-year mortality was 38.1%. Optimised patient selection and improved access site management are mandatory to improve outcomes.
Ludwig et al. (Tue,) studied this question.